Cigna Group (NYSE:CI) Given Consensus Rating of “Moderate Buy” by Brokerages

Shares of Cigna Group (NYSE:CI) have earned a consensus rating of “Moderate Buy” from the twenty-four research firms that are covering the firm, MarketBeat reports. One analyst has rated the stock with a sell rating, three have issued a hold rating, nineteen have issued a buy rating and one has issued a strong buy rating on the company. The average 12-month price target among brokers that have issued a report on the stock in the last year is $331.8261.

A number of brokerages have weighed in on CI. JPMorgan Chase & Co. reduced their price target on Cigna Group from $428.00 to $375.00 and set an “overweight” rating for the company in a research report on Tuesday, November 4th. Barclays reduced their target price on Cigna Group from $383.00 to $300.00 and set an “overweight” rating for the company in a report on Friday, October 31st. Leerink Partners lowered their price target on Cigna Group from $300.00 to $270.00 in a report on Friday, October 31st. Zacks Research lowered shares of Cigna Group from a “hold” rating to a “strong sell” rating in a research report on Monday, November 3rd. Finally, Raymond James Financial reiterated a “strong-buy” rating on shares of Cigna Group in a research note on Monday, November 3rd.

Insider Buying and Selling at Cigna Group

In related news, CEO David Cordani acquired 4,134 shares of the business’s stock in a transaction dated Monday, November 3rd. The stock was acquired at an average price of $241.88 per share, with a total value of $999,931.92. Following the completion of the transaction, the chief executive officer owned 157,935 shares of the company’s stock, valued at approximately $38,201,317.80. This represents a 2.69% increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, insider Brian C. Evanko sold 5,368 shares of Cigna Group stock in a transaction dated Friday, October 3rd. The stock was sold at an average price of $300.00, for a total value of $1,610,400.00. Following the sale, the insider directly owned 51,182 shares in the company, valued at approximately $15,354,600. This trade represents a 9.49% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Company insiders own 0.70% of the company’s stock.

Hedge Funds Weigh In On Cigna Group

A number of hedge funds and other institutional investors have recently made changes to their positions in the business. Massachusetts Financial Services Co. MA increased its stake in shares of Cigna Group by 1.1% in the 2nd quarter. Massachusetts Financial Services Co. MA now owns 11,778,472 shares of the health services provider’s stock valued at $3,893,727,000 after acquiring an additional 123,479 shares during the last quarter. Dodge & Cox grew its holdings in Cigna Group by 4.0% during the third quarter. Dodge & Cox now owns 9,305,225 shares of the health services provider’s stock valued at $2,682,231,000 after purchasing an additional 354,615 shares during the period. Sanders Capital LLC increased its stake in Cigna Group by 0.5% in the third quarter. Sanders Capital LLC now owns 7,828,168 shares of the health services provider’s stock valued at $2,256,469,000 after purchasing an additional 35,150 shares in the last quarter. Valeo Financial Advisors LLC raised its holdings in Cigna Group by 86,071.1% in the second quarter. Valeo Financial Advisors LLC now owns 3,475,282 shares of the health services provider’s stock worth $1,148,859,000 after purchasing an additional 3,471,249 shares during the period. Finally, Norges Bank bought a new position in shares of Cigna Group during the second quarter worth $1,110,426,000. 86.99% of the stock is owned by institutional investors.

Cigna Group Trading Up 0.5%

NYSE:CI opened at $276.34 on Monday. The company has a market capitalization of $73.82 billion, a P/E ratio of 12.19, a P/E/G ratio of 1.00 and a beta of 0.25. The stock’s 50 day moving average price is $275.25 and its 200 day moving average price is $291.27. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.76 and a current ratio of 0.76. Cigna Group has a 52 week low of $239.51 and a 52 week high of $350.00.

Cigna Group (NYSE:CI) last posted its earnings results on Thursday, October 30th. The health services provider reported $7.83 EPS for the quarter, topping the consensus estimate of $7.64 by $0.19. The company had revenue of $69.57 billion during the quarter, compared to the consensus estimate of $66.40 billion. Cigna Group had a net margin of 2.29% and a return on equity of 18.80%. The company’s revenue for the quarter was up 9.5% compared to the same quarter last year. During the same period in the previous year, the firm posted $7.51 earnings per share. Cigna Group has set its FY 2025 guidance at 29.600- EPS. On average, research analysts forecast that Cigna Group will post 29.77 EPS for the current fiscal year.

Cigna Group Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Thursday, December 18th. Shareholders of record on Thursday, December 4th were given a $1.51 dividend. This represents a $6.04 annualized dividend and a yield of 2.2%. The ex-dividend date of this dividend was Thursday, December 4th. Cigna Group’s payout ratio is currently 26.64%.

Cigna Group Company Profile

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.